MJP Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
7,051
+245
| +4% | +$45.5K | 0.19% | 51 |
|
|
2025
Q1 | $1.43M | Buy |
6,806
+619
| +10% | +$130K | 0.26% | 43 |
|
|
2024
Q4 | $1.1M | Buy |
6,187
+482
| +8% | +$85.7K | 0.2% | 54 |
|
|
2024
Q3 | $1.13M | Buy |
5,705
+942
| +20% | +$186K | 0.21% | 57 |
|
|
2024
Q2 | $817K | Sell |
4,763
-136
| -3% | -$23.3K | 0.17% | 67 |
|
|
2024
Q1 | $892K | Buy |
4,899
+736
| +18% | +$134K | 0.19% | 62 |
|
|
2023
Q4 | $645K | Sell |
4,163
-694
| -14% | -$108K | 0.17% | 65 |
|
|
2023
Q3 | $724K | Sell |
4,857
-149
| -3% | -$22.2K | 0.21% | 46 |
|
|
2023
Q2 | $674K | Sell |
5,006
-3,252
| -39% | -$438K | 0.22% | 50 |
|
|
2023
Q1 | $1.32M | Buy |
8,258
+364
| +5% | +$58K | 0.4% | 28 |
|
|
2022
Q4 | $1.28M | Buy |
7,894
+506
| +7% | +$81.8K | 0.37% | 33 |
|
|
2022
Q3 | $992K | Sell |
7,388
-236
| -3% | -$31.7K | 0.3% | 36 |
|
|
2022
Q2 | $1.17M | Buy |
7,624
+102
| +1% | +$15.6K | 0.33% | 32 |
|
|
2022
Q1 | $1.22M | Buy |
7,522
+1,060
| +16% | +$172K | 0.31% | 37 |
|
|
2021
Q4 | $875K | Buy |
6,462
+757
| +13% | +$103K | 0.26% | 52 |
|
|
2021
Q3 | $615K | Buy |
5,705
+301
| +6% | +$32.4K | 0.21% | 60 |
|
|
2021
Q2 | $609K | Buy |
5,404
+409
| +8% | +$46.1K | 0.2% | 57 |
|
|
2021
Q1 | $541K | Buy |
4,995
+234
| +5% | +$25.3K | 0.22% | 57 |
|
|
2020
Q4 | $510K | Buy |
+4,761
| New | +$510K | 0.21% | 57 |
|